A recent ruling by the Advertising Regulatory Board (ARB) in a dispute between Beiersdorf and L'Oréal has provided valuable regulatory guidance on the use of market leadership claims and health professional endorsement claims in cosmetic advertising for science-led beauty brands.
The ruling confirms that claims such as “South Africa’s No.1 Dermatologist Recommended Brand” can be made, provided they are supported by robust, statistically significant and independently validated evidence that exists at the time the claim is published. But there is more to this than meets the eye....
At first glance, the ruling appears to concern a relatively narrow dispute over dermatologist recommendations. In reality, it has far broader implications for cosmetic companies that rely on claims such as "No.1", "Most Recommended", "Expert Recommended", "Dermatologist Recommended", "Dentist Recommended" or other forms of professional endorsement to differentiate their brands.
The broader significance lies in how the ARB interpreted market research evidence & its relevance to the claim being made, the validity of professional endorsement claims and the use of competing survey data to support seemingly similar market leadership positions.
The ruling confirms that professional endorsement claims such as "No.1 Dermatologist Recommended" remain permissible where supported by statistically robust, independently conducted and professionally validated market research. However, the Directorate went further by recognising that competing advertisers may each possess credible survey evidence supporting similar leadership claims. In one of the most commercially important observations in the decision, the ARB acknowledged that two independently conducted surveys, undertaken using different but equally valid methodologies, may legitimately arrive at different conclusions. In practical terms, this means that competing brands could simultaneously hold substantiated "No.1" positions depending on survey design, sample composition and timing. The question then becomes: Who does the consumer believe?
This finding has potentially significant implications for the dermo-cosmetic sector, where dermatologist recommendation claims have become a key competitive differentiator. It signals that the regulatory focus is shifting away from determining a single objective market winner and toward assessing whether a claim was adequately substantiated at the time it was made.
The decision also reinforces an important principle contained within the ARB Code of Practice that market survey data is not indefinite. Market leadership and recommendation claims require ongoing substantiation and periodic refreshment because market conditions, professional preferences and competitive dynamics evolve over time. Brands relying on historic survey data may therefore find themselves increasingly vulnerable to challenge as newer market data evidence emerges.
For cosmetic companies, this elevates market research from a compliance exercise to a strategic asset. Professional recommendation surveys are increasingly becoming part of a brand's competitive armoury, capable of supporting premium positioning, strengthening scientific credibility and defending market leadership narratives in highly contested categories such as acne care, pigmentation, anti-ageing and sun protection.
From a regulatory and public affairs perspective, the ruling also demonstrates the increasing sophistication of competitor challenges. Future disputes are likely to focus less on whether substantiation exists and more on the quality of survey methodology, statistical significance, sample design, survey recency and expert validation. As a result, companies may need to apply the same level of governance to market research programmes as they do to clinical efficacy studies.
The most forward-looking beauty companies should view this ruling as a catalyst to strengthen claims governance frameworks. Dermatologist recommendation claims, healthcare professional endorsements and market leadership positions should be supported by structured annual survey programmes, independent expert validation and clearly documented substantiation files capable of withstanding competitor scrutiny.
Businesses should also anticipate a future where "claim wars" increasingly replace traditional advertising disputes. As brands compete for scientific authority and professional endorsement, investment in credible market intelligence may become as strategically important as investment in product innovation itself.
Bottom Line Take Out
The ARB has effectively confirmed that in the modern beauty industry, "No.1" is not a permanent title, it is a substantiated position that must be continuously earned, monitored and defended. The winners will not necessarily be the brands with the loudest marketing campaigns, but those with the strongest evidence, the most disciplined claims governance systems and the foresight to refresh their substantiation before competitors challenge it. In an increasingly science-driven beauty market, market research has evolved from supporting advertising to becoming a competitive and regulatory asset in its own right.
